Jonathon Holt is an experienced professional in nonclinical development and project management, currently serving as Vice President of Nonclinical Development at atai Life Sciences. Previously, Jonathon held the role of Senior Director of Nonclinical Development at both Nuventra Pharma Sciences and Intarcia Therapeutics, Inc., as well as serving as a Senior Consultant at Schwarz Holt Consulting. Jonathon's expertise extends to product development, demonstrated during tenure as Executive Director of Product Development at E-Scape Bio. Academic credentials include a PhD in Psychopharmacology from Durham University and a BSc (Hons) in Physiology and Pharmacology from The University of Manchester.